(Adds details of study and background in paragraphs 2,3,4)
July 26 (Reuters) -
Moderna and drugmaker Merck have started a late-stage study to evaluate their experimental mRNA-based cancer vaccine in combination with cancer therapy Keytruda, the companies said on Wednesday.
The companies will study the safety and efficacy of the vaccine-Keytruda combination in patients with a type of skin cancer, compared to Keytruda alone.
Global recruitment for the trial has begun, with the first patients being enrolled in Australia, the companies said in a joint release.
Shares of Moderna rose 1% in premarket trading.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)
"stage" - Google News
July 26, 2023 at 06:03PM
https://ift.tt/vAQWTNu
UPDATE 1-Moderna/Merck begin late-stage study of mRNA cancer vaccine - Yahoo Finance
"stage" - Google News
https://ift.tt/x75No63
https://ift.tt/IH1UdDi
Bagikan Berita Ini
0 Response to "UPDATE 1-Moderna/Merck begin late-stage study of mRNA cancer vaccine - Yahoo Finance"
Post a Comment